Literature DB >> 11961012

Mutations in theCOL4A4 and COL4A3 genes cause familial benign hematuria.

Cèlia Badenas1,1, Manuel Praga1, Bárbara Tazón1,1, Laurence Heidet1, Christelle Arrondel1, Anna Armengol1,1, Amado Andrés1, Enrique Morales1, Juan Antonio Camacho1, Xose Lens1, Sonia Dávila1, Montse Milà1, Corinne Antignac1, Alejandro Darnell1, Roser Torra1.   

Abstract

Familial benign hematuria (FBH) is a common autosomal dominant disorder characterized by the presence of persistent or recurrent hematuria. The clinical and pathologic features of this syndrome resemble those of early Alport syndrome (AS), and for this reason a common molecular defect has been proposed. The COL4A3/4 genes seem to be involved in both autosomal AS and FBH. This study involves a linkage analysis for the COL4A3/4 loci and a search for mutations within these genes in 11 biopsy-proven FBH families. Haplotype analysis showed that linkage to the COL4A3/4 locus could not be excluded in eight of nine families. One family was not linked to this locus; however, it included three affected women who could be X-linked AS carriers. Two families were too small to perform linkage analysis. COL4A3 and COL4A4 mutation screening disclosed six new pathogenic mutations, two in the COL4A3 gene (G985V and G1015E) and four in the COL4A4 gene (3222insA, IVS23-1G>C, 31del11, and G960R). It is the first time that mutations within the COL4A3 gene are described in families with FBH. This study clearly demonstrates the main role of the COL4A4 and COL4A3 genes in the pathogenesis of FBH.

Entities:  

Mesh:

Year:  2002        PMID: 11961012     DOI: 10.1681/ASN.V1351248

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  34 in total

1.  Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases.

Authors:  Kesha Rana; Stephen Tonna; Yan Yan Wang; Lydia Sin; Tina Lin; Elizabeth Shaw; Ishanee Mookerjee; Judy Savige
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

Review 2.  Living donor kidney transplantation in patients with hereditary nephropathies.

Authors:  Patrick Niaudet
Journal:  Nat Rev Nephrol       Date:  2010-09-28       Impact factor: 28.314

3.  Internal carotid artery dissection, cerebral aneurysms and thin basement membrane nephropathy.

Authors:  Nicholas J Cutfield; John L Wilson; L Jonathan Zwi; Barry J Snow
Journal:  J Neurol       Date:  2009-01-23       Impact factor: 4.849

4.  Type IV procollagen missense mutations associated with defects of the eye, vascular stability, the brain, kidney function and embryonic or postnatal viability in the mouse, Mus musculus: an extension of the Col4a1 allelic series and the identification of the first two Col4a2 mutant alleles.

Authors:  Jack Favor; Christian Johannes Gloeckner; Dirk Janik; Martina Klempt; Angelika Neuhäuser-Klaus; Walter Pretsch; Wolfgang Schmahl; Leticia Quintanilla-Fend
Journal:  Genetics       Date:  2006-12-18       Impact factor: 4.562

5.  A novel COL4A3 mutation causes autosomal-recessive Alport syndrome in a large Turkish family.

Authors:  Asli Subasioglu Uzak; Bulent Tokgoz; Munis Dundar; Mustafa Tekin
Journal:  Genet Test Mol Biomarkers       Date:  2013-01-08

Review 6.  The Role of Collagens in Peripheral Nerve Myelination and Function.

Authors:  Peiwen Chen; Matilde Cescon; Paolo Bonaldo
Journal:  Mol Neurobiol       Date:  2014-08-21       Impact factor: 5.590

7.  Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold.

Authors:  Roman David Bülow; Peter Boor
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

8.  COL4A4 gene study of a European population: description of new mutations causing autosomal dominant Alport syndrome.

Authors:  Consolación Rosado; Elena Bueno; Carmen Felipe; Rogelio González-Sarmiento
Journal:  Int J Mol Epidemiol Genet       Date:  2014-12-15

9.  A meta-analysis of genome-wide data from five European isolates reveals an association of COL22A1, SYT1, and GABRR2 with serum creatinine level.

Authors:  Cristian Pattaro; Alessandro De Grandi; Veronique Vitart; Caroline Hayward; Andre Franke; Yurii S Aulchenko; Asa Johansson; Sarah H Wild; Scott A Melville; Aaron Isaacs; Ozren Polasek; David Ellinghaus; Ivana Kolcic; Ute Nöthlings; Lina Zgaga; Tatijana Zemunik; Carsten Gnewuch; Stefan Schreiber; Susan Campbell; Nick Hastie; Mladen Boban; Thomas Meitinger; Ben A Oostra; Peter Riegler; Cosetta Minelli; Alan F Wright; Harry Campbell; Cornelia M van Duijn; Ulf Gyllensten; James F Wilson; Michael Krawczak; Igor Rudan; Peter P Pramstaller
Journal:  BMC Med Genet       Date:  2010-03-11       Impact factor: 2.103

10.  A family with X-linked benign familial hematuria.

Authors:  Kazunari Kaneko; Sachiyo Tanaka; Masafumi Hasui; Kandai Nozu; Rafal Przybyslaw Krol; Kazumoto Iijima; Keisuke Sugimoto; Tsukasa Takemura
Journal:  Pediatr Nephrol       Date:  2010-03       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.